Evidence map›Paper›PMID 31788541›Full record

ArticleEndoscopy international open2019

Gastric mucosal devitalization improves blood pressure, renin and cardiovascular lipid deposition in a rat model of obesity.

Andreas Oberbach, Nadine Schlichting, Yvonne Kullnick, Marco Heinrich, Stefanie Lehmann, Ulf Retschlag, Maik Friedrich, Lea Fayad, Arne Dietrich, Mouen A Khashab and 2 more

3 registry-linked trialsOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Endoscopy international open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05486338 nacompletednot on this mapstarted 2023, after this paper: background citation

Endoscopic Gastric Mucosal Ablation (GMA) as a Primary Obesity Therapy Early Feasibility [COMET EF] - Step II

TypeinterventionalSponsorErbe Elektromedizin GmbHRan2023 to 2025Enrolled15ConditionsObesity, AdiposityArmsHybrid Argon Plasma Coagulation (HAPC)
NCT05574777 nacompletednot on this mapstarted 2023, after this paper: background citation

Safety and Feasibility of HybridAPC for Gastric Mucosal Ablation in the Management of Patients With Class III Obesity

TypeinterventionalSponsorErbe Elektromedizin GmbHRan2023 to 2026Enrolled13ConditionsAdiposity, Morbid, ObesityArmsHybrid Argonplasma coagulation (HAPC)
NCT05587491 nacompletednot on this mapstarted 2023, after this paper: background citation

Feasibility and Safety of HybridAPC for Gastric Mucosal Ablation in the Management of Patients With Obesity.

TypeinterventionalSponsorErbe Elektromedizin GmbHRan2023 to 2025Enrolled15ConditionsObesity, AdiposityArmsHybrid Argonplasma coagulation (HAPC)
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Endoscopic Procedures for Weight Loss.Current obesity reports · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Andreas OberbachDepartment of Medicine and Division of Gastroenterology and Hepatology. The Johns Hopkins Medical Institutions, Baltimore, Maryland, United States.
Nadine SchlichtingFraunhofer Institute for Cell Therapy and Immunology, Department of Diagnostics, Leipzig, Germany.
Yvonne KullnickFraunhofer Institute for Cell Therapy and Immunology, Department of Diagnostics, Leipzig, Germany.
Marco HeinrichFraunhofer Institute for Cell Therapy and Immunology, Department of Diagnostics, Leipzig, Germany.
Stefanie LehmannFraunhofer Institute for Cell Therapy and Immunology, Department of Diagnostics, Leipzig, Germany.
Ulf RetschlagDepartment of Visceral, Transplantation, Thoracic and Vascular Surgery, Leipzig University Hospital, Leipzig, Germany.
Maik FriedrichFraunhofer Institute for Cell Therapy and Immunology, Department of Diagnostics, Leipzig, Germany.
Lea FayadDepartment of Medicine and Division of Gastroenterology and Hepatology. The Johns Hopkins Medical Institutions, Baltimore, Maryland, United States.
Arne DietrichIntegrated Research and Treatment Centre Obesity Diseases, Leipzig University, Leipzig, Germany.
Mouen A KhashabDepartment of Medicine and Division of Gastroenterology and Hepatology. The Johns Hopkins Medical Institutions, Baltimore, Maryland, United States.
Anthony N KallooDepartment of Medicine and Division of Gastroenterology and Hepatology. The Johns Hopkins Medical Institutions, Baltimore, Maryland, United States.
Vivek KumbhariDepartment of Medicine and Division of Gastroenterology and Hepatology. The Johns Hopkins Medical Institutions, Baltimore, Maryland, United States.
Johns Hopkins University · USFraunhofer Institute for Cell Therapy and Immunology · DEUniversity Hospital Leipzig · DELeipzig University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID31788541
PMCPMC6877424
OpenAlexW2989894969

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.